midazolam has been researched along with Bronchiolitis in 3 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Bronchiolitis: Inflammation of the BRONCHIOLES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to develop a population pharmacokinetic model of midazolam, and to evaluate the influence of maturation process and other variability factors in critically ill children with severe acute bronchiolitis, who received a long-term intravenous infusion of midazolam." | 9.34 | Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis. ( Grabnar, I; Grosek, Š; Jovanović, M; Kos, MK; Miksić, M; Roškar, R, 2020) |
| "The aim of the present study was to develop a population pharmacokinetic model of midazolam, and to evaluate the influence of maturation process and other variability factors in critically ill children with severe acute bronchiolitis, who received a long-term intravenous infusion of midazolam." | 5.34 | Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis. ( Grabnar, I; Grosek, Š; Jovanović, M; Kos, MK; Miksić, M; Roškar, R, 2020) |
| "Conditions precipitating acute respiratory failure (ARF) were classified into two groups: type 1 (38 episodes) and type 2 (78 episodes)." | 1.35 | Predictive factors of non invasive ventilation failure in critically ill children: a prospective epidemiological study. ( Concha, A; Díaz, JJ; Los Arcos, M; Mayordomo-Colunga, J; Medina, A; Menéndez, S; Rey, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kos, MK | 1 |
| Miksić, M | 1 |
| Jovanović, M | 1 |
| Roškar, R | 1 |
| Grosek, Š | 1 |
| Grabnar, I | 1 |
| Mayordomo-Colunga, J | 1 |
| Medina, A | 1 |
| Rey, C | 1 |
| Díaz, JJ | 1 |
| Concha, A | 1 |
| Los Arcos, M | 1 |
| Menéndez, S | 1 |
| Bouchut, JC | 1 |
| Mallet, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Efficacy and Safety of Gastric Feeding in Critically Ill Pediatric Patients Receiving Non-invasive Positive Pressure Ventilation: A Pilot Study[NCT01301352] | 30 participants (Actual) | Interventional | 2011-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for midazolam and Bronchiolitis
| Article | Year |
|---|---|
Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis.
Topics: ATP Binding Cassette Transporter, Subfamily B; Bronchiolitis; Critical Illness; Female; Humans; Hypn | 2020 |
2 other studies available for midazolam and Bronchiolitis
| Article | Year |
|---|---|
Predictive factors of non invasive ventilation failure in critically ill children: a prospective epidemiological study.
Topics: Adolescent; Anti-Anxiety Agents; Anxiety; Asthma; Bronchiolitis; Child; Child, Preschool; Critical I | 2009 |
Weaning directly from high frequency oscillatory ventilation: the 'open lung' strategy expanded to weaning?
Topics: Anesthetics, Intravenous; Blood Gas Analysis; Bronchiolitis; Bronchodilator Agents; Female; Fentanyl | 2004 |